Insitro
Machine learning-driven drug discovery and development company
About Insitro
insitro is a machine learning-driven drug discovery and development company that combines computational methods with experimental biology. The company studies human disease biology and uses large-scale biological and clinical data to identify therapeutic opportunities and develop medicines with the potential to address significant diseases. insitro’s platform brings together machine learning, human genetics, cellular disease models, and high-content biological data. Its discovery work includes target identification and validation, molecule design, and development of small molecules and other therapeutic modalities. The company advances its own research pipeline and collaborates with pharmaceutical and research partners to apply data science and biology to drug development challenges. The insitro approach is intended to make drug discovery more systematic by connecting insights about disease mechanisms with experimental testing and therapeutic design. Researchers and industry partners interested in AI drug discovery, computational biology, or machine learning for medicine can learn about its work across areas including metabolism, neuroscience, and ophthalmology.
AI Tools & Services
No AI tools listed yet.
Reviews
No reviews yet.
Similar AI Companies
Hadrian
Autonomous manufacturing company using AI and advanced robotics for precision aerospace parts
Fictiv
Digital manufacturing ecosystem using AI to streamline hardware development and sourcing
Hubs
Digital manufacturing platform using AI to connect designers with a global network of suppliers
Xometry
On-demand manufacturing platform using AI to instantly price and route custom parts